Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/15/2005WO2005118855A1 Assay system using labeled oligonucleotides
12/15/2005WO2005118854A1 Fcgr3a gebotype and methods for evaluating treatment response to non-depleting antibodies
12/15/2005WO2005118853A2 Recombinase polymerase amplification
12/15/2005WO2005118852A2 A marker for prenatal diagnosis and monitoring
12/15/2005WO2005118851A1 Oligonucleotides for cancer diagnosis
12/15/2005WO2005118850A1 Method for selecting or obtaining plants which are resistant to pvmv.
12/15/2005WO2005118849A1 Method for stabilizing assay reagents, reagent container with stabilized assay reagents and use thereof
12/15/2005WO2005118848A1 Biomarkers for the prediction of responsiveness to clozapine treatment
12/15/2005WO2005118847A1 Detection of target nucleotide sequences using an asymmetric oligonucleotide ligation assay
12/15/2005WO2005118846A1 Detection of subjects at risk for chd by a genotype evaluation associated with serum plant sterols enabling individualized (drug) treatment on demand
12/15/2005WO2005118845A2 Use of a genetic modification in the human gnaq gene for predicting risk of disease, the course of a disease, and reaction to treatments
12/15/2005WO2005118844A1 Addressable molecular probe assembly
12/15/2005WO2005118843A1 Compositions and methods
12/15/2005WO2005118842A1 Method for measuring enzyme activity and column for use in measuring enzyme activity
12/15/2005WO2005118841A1 Assay of ubiquitinization of synoviolin and use thereof in screening
12/15/2005WO2005118840A2 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10)
12/15/2005WO2005118839A1 Method and reagent for measuring nitroreductase enzyme activity
12/15/2005WO2005118838A2 Adjustable test system for the determination of the presence of an antibiotic in a fluid
12/15/2005WO2005118837A1 High ph test system for the determination of the presence of an antibiotic in a fluid
12/15/2005WO2005118836A2 Hif prolyl hydroxylase activity assay
12/15/2005WO2005118835A2 Cell lines and methods for evaluating integrating polynucleotides
12/15/2005WO2005118834A2 Methods for identifying risk of breast cancer and treatment thereof
12/15/2005WO2005118833A2 Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak)
12/15/2005WO2005118832A2 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
12/15/2005WO2005118817A1 Method for high speed screening for the identification of molecules inhibiting the activity of editing enzymes
12/15/2005WO2005118815A1 Polypeptides having dna polymerase activity
12/15/2005WO2005118810A1 Agents and methods for diagnosing stress
12/15/2005WO2005118809A2 Methods and compositions for enhancing cell adhesion properties
12/15/2005WO2005118804A1 Method of specifically detecting bacterium belonging to the genus alicyclobacillus
12/15/2005WO2005118796A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
12/15/2005WO2005118791A1 Exhaustive gene expression profiling analysis using microsample
12/15/2005WO2005118787A2 Method of screening candidate compounds for susceptibility to biliary excretion
12/15/2005WO2005118783A1 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
12/15/2005WO2005118773A2 Apparatus and methods for multiplex analyses
12/15/2005WO2005118403A2 Methods for detecting gene expression in peripheral blood cells and uses thereof
12/15/2005WO2005117959A2 NEEDLE-FREE ADMINISTRATION OF FeLV BVACCINES
12/15/2005WO2005117950A2 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
12/15/2005WO2005117943A2 Biomarkers for monitoring inhibition of impdh pathway
12/15/2005WO2005117897A2 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005WO2005117859A2 Methods of diagnosing cardiovascular disease
12/15/2005WO2005117553A2 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
12/15/2005WO2005117532A2 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005WO2005117514A2 Method of detecting cystic fibrosis associated mutations
12/15/2005WO2005108610A3 Methods for the selection of subjects for multiple sclerosis therapy
12/15/2005WO2005106041A3 Kits and reagents for use in diagnosis and prognosis of genomic disorders
12/15/2005WO2005106012A3 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
12/15/2005WO2005103298A3 Method for detecting ncrna
12/15/2005WO2005100589A3 Kinetic process for the detection, diagnosis, processing, and monitoring of clonal cell populations
12/15/2005WO2005098442A3 Assay system and method for direct measurement of ldl cholesterol
12/15/2005WO2005098438B1 Analysis array comprising heatable electrodes, and methods for chemical and biochemical analysis
12/15/2005WO2005098046A3 Methods for the determination of cell specific biomarkers
12/15/2005WO2005098029A3 Methods for quantification of micrornas and small interfering rnas
12/15/2005WO2005087953A8 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
12/15/2005WO2005083126A3 Alterations of fibulin genes in macular degeneration
12/15/2005WO2005080588A3 2031 oxidoreductase
12/15/2005WO2005075666A3 Diagnostics and therapeutics for diseases associated with puromycin sensitive aminopeptidase npepps (npepps)
12/15/2005WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
12/15/2005WO2005067425A3 Bacterial biosensors
12/15/2005WO2005060541A3 Peptides and methods for inducing cellular resistance to infection
12/15/2005WO2005046564A3 Diagnosis and treatment of liver fibrosis
12/15/2005WO2005045075A3 Sample preparation methods and devices
12/15/2005WO2005044091A3 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
12/15/2005WO2005040755A3 Nanoscale transduction systems for detecting molecular interactions
12/15/2005WO2005039501A3 Immunogenic composition and method of developing a vaccine based on fusion protein
12/15/2005WO2005034735A3 Method for assessing the risk for insulin resistant diabetes and/or heart disease
12/15/2005WO2005032328A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/15/2005WO2005024695A8 Methods for encoding non-biological information on microarrays
12/15/2005WO2005023993A3 Methods and compositions for generation of germline human antibody genes
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2005001142A3 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
12/15/2005WO2004105573A3 Method of diagnosis of cancer based on gene expression profiles in cells
12/15/2005WO2004101764A3 Methods of modulating metastasis and skeletal related events resulting from metastases
12/15/2005WO2004097581A3 Computational method and system for mass spectral analysis
12/15/2005WO2004091526A3 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
12/15/2005WO2004067726A3 Isothermal reactions for the amplification of oligonucleotides
12/15/2005WO2004064737A3 Therapeutics compositions
12/15/2005WO2004057015A3 Detecting a nucleic acid
12/15/2005WO2004048511A3 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
12/15/2005WO2004047757A3 Diagnosing and treating hematopoietic cancers
12/15/2005WO2004012588A3 Use of biomarkers for detecting ovarian cancer
12/15/2005WO2004000102A3 Method for predicting response to epidermal growth factor receptor-directed therapy
12/15/2005WO2003029409A3 Methods for generating, selecting, and identifying compounds which bind a target molecule
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050278806 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
12/15/2005US20050278804 Methods for coupling resistance alleles in tomato
12/15/2005US20050278801 Plastid transit peptides
12/15/2005US20050278800 Compositions and methods for the modification of gene expression
12/15/2005US20050278796 FIAT nucleic acids and proteins and uses thereof
12/15/2005US20050277766 Udp-glucose aglycon-glucosytransferase
12/15/2005US20050277618 Methods
12/15/2005US20050277612 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/15/2005US20050277610 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277607 Compositions and methods for regulating peptidyltransferase activity and uses thereof
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277587 CD7 as biomarker and therapeutic target for psoriasis
12/15/2005US20050277205 Multicomponent magnetic nanorods for biomolecular separations
12/15/2005US20050277204 Sample preparation methods and devices
12/15/2005US20050277197 Microparticles with multiple fluorescent signals and methods of using same
1 ... 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 ... 3003